Last reviewed · How we verify

NCT03731936

Artificial Intelligence to Assess the Association Between Facial Characteristics and Coronary Artery Diseases

Completed Last updated 20 August 2019
What this trial tests

trial testing No intervention in Coronary Artery Disease in 6,864 participants. Completed in 2 August 2019.

Timeline
10 July 2017
Primary endpoint
2 August 2019
2 August 2019

Quick facts

Lead sponsorChina National Center for Cardiovascular Diseases
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6,864
Start date10 July 2017
Primary completion2 August 2019
Estimated completion2 August 2019
Sites9 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

China National Center for Cardiovascular Diseases — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this study are 1) to explore the association between facial characteristics and the increased risk of coronary artery diseases; 2) to evaluate the diagnostic efficacy of appearance factors for coronary artery diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other China National Center for Cardiovascular Diseases trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03731936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing